The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA - PubMed (original) (raw)
The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA
A H Ross et al. J Cell Biol. 1996 Mar.
Abstract
The high-affinity NGF receptor is thought to be a complex of two receptors , gp75 and the tyrosine kinase TrkA, but direct biochemical evidence for such an association had been lacking. In this report, we demonstrate the existence of such a gp75-TrkA complex by a copatching technique. Gp75 on the surface of intact cells is patched with an anti-gp75 antibody and fluorescent secondary antibody, the cells are then fixed to prevent further antibody-induced redistributions, and the distribution of TrkA is probed with and anti-TrkA antibody and fluorescent secondary antibody. We utilize a baculovirus-insect cell expression of wild-type and mutated NGF receptors. TrkA and gp75 copatch in both the absence and presence of NGF. The association is specific, since gp75 does not copatch with other tyrosine kinase receptors, including TrkB, platelet-derived growth factor receptor-beta, and Torso (Tor). To determine which domains of TrkA are required for copatching, we used a series of TrkA-Tor chimeric receptors and show that the extracellular domain of TrkA is sufficient for copatching with gp75. A chimeric receptor with TrkA transmembrane and intracellular domains show partial copatching with gp75. Deletion of the intracellular domain of gp75 decreases but does not eliminate copatching. A point mutation which inactivates the TrkA kinase has no effect on copatching, indicating that this enzymatic activity is not required for association with gp75. Hence, although interactions between the gp75 and TrkA extracellular domains are sufficient for complex formation, interactions involving other receptor domains also play a role.
Similar articles
- Interaction with TrkA immobilizes gp75 in the high affinity nerve growth factor receptor complex.
Wolf DE, McKinnon CA, Daou MC, Stephens RM, Kaplan DR, Ross AH. Wolf DE, et al. J Biol Chem. 1995 Feb 3;270(5):2133-8. doi: 10.1074/jbc.270.5.2133. J Biol Chem. 1995. PMID: 7836442 - Mobility of TrkA is regulated by phosphorylation and interactions with the low-affinity NGF receptor.
Wolf DE, McKinnon-Thompson C, Daou MC, Stephens RM, Kaplan DR, Ross AH. Wolf DE, et al. Biochemistry. 1998 Mar 3;37(9):3178-86. doi: 10.1021/bi9719253. Biochemistry. 1998. PMID: 9485472 - Modulation of nerve growth factor internalization by direct interaction between p75 and TrkA receptors.
Gargano N, Levi A, Alema S. Gargano N, et al. J Neurosci Res. 1997 Oct 1;50(1):1-12. doi: 10.1002/(SICI)1097-4547(19971001)50:1<1::AID-JNR1>3.0.CO;2-N. J Neurosci Res. 1997. PMID: 9379485 - p75 and Trk: a two-receptor system.
Chao MV, Hempstead BL. Chao MV, et al. Trends Neurosci. 1995 Jul;18(7):321-6. Trends Neurosci. 1995. PMID: 7571013 Review. - Axonal transport of the trkA high-affinity NGF receptor.
Ross AH, Lachyankar MB, Poluha DK, Loy R. Ross AH, et al. Prog Brain Res. 1994;103:15-21. doi: 10.1016/s0079-6123(08)61122-x. Prog Brain Res. 1994. PMID: 7533911 Review. No abstract available.
Cited by
- Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR.
Bibel M, Hoppe E, Barde YA. Bibel M, et al. EMBO J. 1999 Feb 1;18(3):616-22. doi: 10.1093/emboj/18.3.616. EMBO J. 1999. PMID: 9927421 Free PMC article. - Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.
Kanning KC, Hudson M, Amieux PS, Wiley JC, Bothwell M, Schecterson LC. Kanning KC, et al. J Neurosci. 2003 Jul 2;23(13):5425-36. doi: 10.1523/JNEUROSCI.23-13-05425.2003. J Neurosci. 2003. PMID: 12843241 Free PMC article. - Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands.
Maliartchouk S, Saragovi HU. Maliartchouk S, et al. J Neurosci. 1997 Aug 15;17(16):6031-7. doi: 10.1523/JNEUROSCI.17-16-06031.1997. J Neurosci. 1997. PMID: 9236214 Free PMC article. - Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers.
Chen H, Ye Z, Korpershoek JV, Creemers LB, Weinans H, Rios JL. Chen H, et al. Mol Ther Nucleic Acids. 2025 May 5;36(2):102552. doi: 10.1016/j.omtn.2025.102552. eCollection 2025 Jun 10. Mol Ther Nucleic Acids. 2025. PMID: 40487355 Free PMC article. Review. - An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors.
Kong H, Boulter J, Weber JL, Lai C, Chao MV. Kong H, et al. J Neurosci. 2001 Jan 1;21(1):176-85. doi: 10.1523/JNEUROSCI.21-01-00176.2001. J Neurosci. 2001. PMID: 11150334 Free PMC article.
References
- J Biol Chem. 1995 Feb 3;270(5):2133-8 - PubMed
- EMBO J. 1994 Dec 1;13(23):5581-9 - PubMed
- J Cell Biol. 1995 Jul;130(1):149-56 - PubMed
- J Neurosci Res. 1995 Mar 1;40(4):557-63 - PubMed
- Science. 1994 Sep 9;265(5178):1596-9 - PubMed